BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 30536763)

  • 1. RhoB antibody alters retinal vascularization in models of murine retinopathy.
    Almonte-Baldonado R; Bravo-Nuevo A; Gerald D; Benjamin LE; Prendergast GC; Laury-Kleintop LD
    J Cell Biochem; 2019 Jun; 120(6):9381-9391. PubMed ID: 30536763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
    Han N; Xu H; Yu N; Wu Y; Yu L
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model.
    Wang J; Lin J; Kaiser U; Wohlfart P; Hammes HP
    Acta Diabetol; 2017 Apr; 54(4):383-392. PubMed ID: 28070752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rice Bran and Vitamin B6 Suppress Pathological Neovascularization in a Murine Model of Age-Related Macular Degeneration as Novel HIF Inhibitors.
    Ibuki M; Lee D; Shinojima A; Miwa Y; Tsubota K; Kurihara T
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies.
    Dai C; Webster KA; Bhatt A; Tian H; Su G; Li W
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.
    Sidman RL; Li J; Lawrence M; Hu W; Musso GF; Giordano RJ; Cardó-Vila M; Pasqualini R; Arap W
    Sci Transl Med; 2015 Oct; 7(309):309ra165. PubMed ID: 26468327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy.
    Dai C; Waduge P; Ji L; Huang C; He Y; Tian H; Zuniga-Sanchez E; Bhatt A; Pang IH; Su G; Webster KA; Li W
    Cell Mol Life Sci; 2022 Jan; 79(1):63. PubMed ID: 35006382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-CBL is required for inhibition of angiogenesis through modulating JAK2/STAT3 activity in ROP development.
    Chen S; Sun Q; Sun D; Willette-Brown J; Anderson MJ; Gu Q; Lewandoski M; Hu Y; Zhu F; Wei F; Zhang J
    Biomed Pharmacother; 2020 Dec; 132():110856. PubMed ID: 33125970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
    Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
    Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β‑elemene inhibits oxygen‑induced retinal neovascularization via promoting miR‑27a and reducing VEGF expression.
    Zhang W; Chen L; Geng J; Liu L; Xu L
    Mol Med Rep; 2019 Mar; 19(3):2307-2316. PubMed ID: 30664207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragalus root extract inhibits retinal cell apoptosis and repairs damaged retinal neovascularization in retinopathy of prematurity.
    Liu X; Wang B; Sun Y; Jia Y; Xu Z
    Cell Cycle; 2019 Nov; 18(22):3147-3159. PubMed ID: 31564208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
    Eyetech Study Group
    Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy.
    Lee YM; Lee YR; Kim CS; Jo K; Sohn E; Kim JS; Kim J
    Int J Mol Sci; 2015 Dec; 16(12):29900-10. PubMed ID: 26694358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model.
    Zhang J; Zhu M; Ruan L; Jiang C; Yang Q; Chang Q; Huang X
    FASEB J; 2020 Dec; 34(12):15822-15836. PubMed ID: 33103304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.
    Di Y; Zhang Y; Yang H; Wang A; Chen X
    Drug Des Devel Ther; 2015; 9():2463-73. PubMed ID: 25995618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
    Mol Vis; 2018; 24():394-406. PubMed ID: 29853773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal Delivery of VEGF-A
    Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S
    Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.
    Budd SJ; Hartnett ME
    Arch Ophthalmol; 2010 May; 128(5):589-95. PubMed ID: 20457980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mediators and Regulators of Retinal Angiogenesis.
    Vishwakarma S; Kaur I
    Semin Ophthalmol; 2023 Feb; 38(2):124-133. PubMed ID: 36536520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy.
    Yun JH; Koh YJ; Jeong HS; Lee DH; Lee EH; Cho CH
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2792-2799. PubMed ID: 30100069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.